Henry Schein | HSIC - Ebitda

Aktienkurs
72.29
Täglich Wechseln
-0.39 -0.54%
Monatlich
-10.28%
Jährlich
4.18%
Q1 Prognose
70.12




Ebitda Veränderung Datum
Agilent USD 540M 74M 2025-09
Align Technology USD 183.84M 19.77M 2025-09
Bruker USD 211.6M 207.4M 2025-12
Cardinal Health USD 981M 5M 2025-12
Charles River Laboratories USD 258.06M 24.83M 2025-12
Cigna USD 2.86B 56M 2025-03
Cooper Companies USD 323.4M 13.2M 2025-12
CVS Health USD 3.74B 349M 2025-12
Danaher USD 2.13B 252M 2025-12
Dentsply International USD 135M 32M 2025-12
Encompass Health USD 335.6M 35.5M 2025-12
Henry Schein USD 291M 4M 2025-12
Idexx Laboratories USD 391.47M 17.97M 2025-09
IQVIA Holdings USD 1.05B 97M 2025-12
Laboratory Of America USD 588.1M 24.1M 2025-12
McKesson USD 1.68B 418M 2025-09
Mettler Toledo International USD 322.64M 26.75M 2025-09
Owens Minor USD 90.02M 2.15M 2025-12
Quest Diagnostics USD 537M 24M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Stryker USD 1.67B 206M 2025-09
Tenet Healthcare USD 1.18B 84M 2025-12
Thermo Fisher Scientific USD 3.17B 335M 2025-12
Universal Health Services USD 678.67M 8.07M 2025-12
Veradigm USD 38.81M 29.61M 2022-09
Waters USD 380.97M 85.83M 2025-12
Zimmer Biomet Holdings USD 759M 120.8M 2025-12
Zoetis USD 1.04B 87M 2025-09